✦ LIBER ✦

Nasal stent fabrication involved in nasal reconstruction: Clinical report of two patient treatments

✍ Scribed by Michael D Brooks; Alan B Carr; Steven E Eckert

Book ID: 113864054
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 466 KB
Volume: 91
Category: Article
ISSN: 1097-6841
DOI: 10.1016/j.prosdent.2003.11.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical aspects and distribution of imm

Clinical aspects and distribution of immunologically active cells in the nasal mucosa of patients with nasal polyps after endoscopic sinus surgery and treatment with topical corticosteroids

✍ A. E. Stoop; H. A. M. D. Heijden; J. Biewenga; S. Baan 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 892 KB

Patient reported outcome measures are an

Patient reported outcome measures are an integral part of clinical outcomes in future treatment recommendations in breast reconstruction

✍ Zoë Winters; J. Mills; J. Mcintosh; A. Bahl; A. Nicholson; A. Reece-Smith 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Azelastine Nasal Spray Compared to Cetir

Azelastine Nasal Spray Compared to Cetirizine in the Treatment of Patients with Seasonal Allergic Rhinitis: a Pooled Analysis of Two Double-Blind, Multicenter Studies.

✍ Sher, E.; Sacks, H. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 158 KB

O-8 Patient reported outcome measures ar

O-8 Patient reported outcome measures are an integral part of clinical outcomes in future treatment recommendations in breast reconstruction

✍ Z.E. Winters; A. Reece-Smith; J. Mills; J. McIntosh; A. Bahl; A. Nicholson; V. B 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 31 KB

A Systematic Review of the Clinical Evid

A Systematic Review of the Clinical Evidence to Guide Treatment Recommendations in Breast Reconstruction Based on Patient-Reported Outcome Measures and Health-Related Quality of Life

✍ Kronowitz, S.J. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Randomized Comparison of Everolimus-Elut

Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting Stents: Two-Year Clinical Follow-Up From the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SPIRIT) III Trial

✍ Stone, G. W.; Midei, M.; Newman, W.; Sanz, M.; Hermiller, J. B.; Williams, J.; F 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 436 KB